Article

Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.

Clin. Infect. Dis. 2013 Jun 1;56(11):1562-9.
Comparative Study

Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.

Ann Pharmacother. 2012 Dec 1;46(12):1587-97.
Article

Evaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureus.

Antimicrob. Agents Chemother. 2014 Aug 1;58(8):4636-41.